Evaluating Routine Blood Tests According to Clinical Symptoms and Diagnostic Criteria in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Ingrid H Baklund, Toril Dammen, Torbjørn Åge Moum, Wenche Kristiansen, Daysi Sosa Duarte, Jesus Castro-Marrero, Ingrid Bergliot Helland, Elin Bolle Strand, Ingrid H Baklund, Toril Dammen, Torbjørn Åge Moum, Wenche Kristiansen, Daysi Sosa Duarte, Jesus Castro-Marrero, Ingrid Bergliot Helland, Elin Bolle Strand

Abstract

There is a lack of research regarding blood tests within individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and between patients and healthy controls. We aimed to compare results of routine blood tests between patients and healthy controls. Data from 149 patients diagnosed with ME/CFS based on clinical and psychiatric evaluation as well as on the DePaul Symptom Questionnaire, and data from 264 healthy controls recruited from blood donors were compared. One-way ANCOVA was conducted to examine differences between ME/CFS patients and healthy controls, adjusting for age and gender. Patients had higher sedimentation rate (mean difference: 1.38, 95% CI: 0.045 to 2.714), leukocytes (mean difference: 0.59, 95% CI: 0.248 to 0.932), lymphocytes (mean difference: 0.27, 95% CI: 0.145 to 0.395), neutrophils (mean difference: 0.34, 95% CI: 0.0 89 to 0.591), monocytes (mean difference: 0.34, 95% CI: 0.309 to 0.371), ferritin (mean difference: 28.13, 95% CI: -1.41 to 57.672), vitamin B12 (mean difference: 83.43, 95% CI: 62.89 to 124.211), calcium (mean difference: 0.02, 95% CI: -0.02 to 0.06), alanine transaminase (mean difference: 3.30, 95% CI: -1.37 to -7.971), low-density lipoproteins (mean difference: 0.45, 95% CI: 0.104 to 0.796), and total proteins (mean difference: 1.53, 95% CI: -0.945 to 4.005) than control subjects. The patients had lower potassium levels (mean difference: 0.11, 95% CI: 0.056 to 0.164), creatinine (mean difference: 2.60, 95% CI: 0.126 to 5.074) and creatine kinase (CK) (mean difference: 37.57, 95% CI: -0.282 to 75.422) compared to the healthy controls. Lower CK and creatinine levels may suggest muscle damage and metabolic abnormalities in ME/CFS patients.

Keywords: creatine kinase; creatinine; diagnostic criteria; functional status; myalgic encephalomyelitis/chronic fatigue syndrome; routine blood tests.

Conflict of interest statement

The authors declare that there is no conflict of interest.

References

    1. Carruthers B.M., Van De Sande M.I., De Meirleir K.L., Klimas N.G., Broderick G., Mitchell T., Staines D., Powles A.C.P., Speight N., Vallings R., et al. Myalgic encephalomyelitis: International consensus criteria. J. Intern. Med. 2011;270:327–338. doi: 10.1111/j.1365-2796.2011.02428.x.
    1. Fukuda K. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann. Intern. Med. 1994;121:953. doi: 10.7326/0003-4819-121-12-199412150-00009.
    1. Carruthers B.M., Jain A.K., De Meirleir K.L., Peterson D.L., Klimas N.G., Lerner A.M., Bested A.C., Henry P.F., Joshi P., Powles A.C.P., et al. Myalgic encephalomyelitis/chronic fatigue syndrome. J. Chronic Fatigue Syndr. 2003;11:7–115. doi: 10.1300/J092v11n01_02.
    1. Jason L.A., Richman J.A., Rademaker A.W., Jordan K.M., Plioplys A.V., Taylor R.R., McCready W., Huang C.-F., Plioplys S. A community-based study of chronic fatigue syndrome. Arch. Intern. Med. 1999;159:2129–2137. doi: 10.1001/archinte.159.18.2129.
    1. Pendergrast T., Brown A., Sunnquist M., Jantke R., Newton J.L., Strand E.B., Jason L.A. Housebound versus non-housebound patients with myalgic encephalomyelitis and chronic fatigue syndrome. Chronic Illn. 2016;12:292–307. doi: 10.1177/1742395316644770.
    1. Estévez-López F., Mudie K., Wang-Steverding X., Bakken I.J., Ivanovs A., Castro-Marrero J., Nacul L., Alegre J., Zalewski P., Slomko J., et al. Systematic review of the epidemiological burden of myalgic encephalomyelitis/chronic fatigue syndrome across europe: Current evidence and EUROMENE research recommendations for epidemiology. J. Clin. Med. 2020;9:1557. doi: 10.3390/jcm9051557.
    1. Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue S, Board on the Health of Select P, Institute of M . The National Academies Collection: Reports funded by National Institutes of Health. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. National Academies Press; Washington, DC, USA: 2015. Copyright 2015 by the National Academy of Sciences. All rights reserved.
    1. Marshall R., Paul L., Wood L. The search for pain relief in people with chronic fatigue syndrome: A descriptive study. Physiother. Theory Pract. 2011;27:373–383. doi: 10.3109/09593985.2010.502554.
    1. Pheby D.F.H., Araja D., Berkis U., Brenna B., Cullinan J., De Korwin J.D., Gitto L., Hughes D.A., Hunter R.M., Trepel D., et al. The development of a consistent Europe-wide approach to investigating the economic impact of ME/CFS: A report from the EUROMENE. Healthcare. 2020;8:88. doi: 10.3390/healthcare8020088.
    1. Smith M.E., Haney E., McDonagh M., Pappas M., Daeges M., Wasson N., Fu R., Nelson H.D. Treatment of myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review for a national institutes of health pathways to prevention workshop. Ann. Intern. Med. 2015;162:841–850. doi: 10.7326/M15-0114.
    1. Nacul L.D.B., Kingdon C., Clark M., De Baros B., Cliff J.M., Mudie K., Dockrell H.M., Laceda E.M. Evidence of clinical pathology abnormalities in people with myalgic encephalomyelitis/chronic fatigue syndrome (me/cfs) from an analytic cross-sectional study. Diagnostics. 2019;9:41. doi: 10.3390/diagnostics9020041.
    1. Richards R.S., Roberts T.K., McGregor N.R., Dunstan R.H., Butt H.L. Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep. 2000;5:35–41. doi: 10.1179/rer.2000.5.1.35.
    1. Niblett S.H., King K.E., Dunstan R.H., Clifton-Bligh P., Hoskin L.A., Roberts T.K., Fulchert G.R., Mcgregor N.R., Dunsmore J.C., Butt H.L. Hematologic and urinary excretion anomalies in patients with chronic fatigue syndrome. Exp. Biol. Med. 2007;232:1041–1049. doi: 10.3181/0702-RM-44.
    1. Van Rensburg S.J., Potocnik F.C.V., Kiss T., Hugo F., Van Zijl P., Mansvelt E., Carstens M.E., TheodoroU P., Huely P.R., Emsley R.A. Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities. Brain Res. Bull. 2001;55:319–325. doi: 10.1016/S0361-9230(01)00478-6.
    1. Ruiz-Núñez B., Tarasse R., Vogelaar E.F., Janneke Dijck-Brouwer D.A., Muskiet F.A.J. Higher Prevalence of “Low T3 Syndrome” in patients with chronic fatigue syndrome: A case–control study. Front. Endocrinol. 2018;9:97. doi: 10.3389/fendo.2018.00097.
    1. Mawle A.C., Nisenbaum R., Dobbins J.G., Gary H.E., Stewart J.A., Reyes M., Steele L., Schmid D.S., Reeves W.C. Immune responses associated with chronic fatigue syndrome: A case-control study. J. Infect. Dis. 1997;175:136–141. doi: 10.1093/infdis/175.1.136.
    1. Swanink C.M.A., Vercoulen J.H.M.M., Bleijenberg G., Fennis J.F.M., Galama J.M.D., Meer J.W.M. Chronic fatigue syndrome: A clinical and laboratory study with a well matched control group. J. Intern. Med. 1995;237:499–506. doi: 10.1111/j.1365-2796.1995.tb00876.x.
    1. Tomic S., Brkic S., Maric D., Mikic A.N. Lipid and protein oxidation in female patients with chronic fatigue syndrome. Arch. Med. Sci. 2012;5:886–891. doi: 10.5114/aoms.2012.31620.
    1. Grant J.E., Veldee M.S., Buchwald D. Analysis of dietary intake and selected nutrient concentrations in patients with chronic fatigue syndrome. J. Am. Diet. Assoc. 1996;96:383–386. doi: 10.1016/S0002-8223(96)00104-6.
    1. Smirnova I.V., Pall M.L. Elevated levels of protein carbonyls in sera of chronic fatigue syndrome patients. Mol. Cell Biochem. 2003;248:93–95. doi: 10.1023/A:1024176016962.
    1. Moorkens G., Berwaerts J., Wynants H., Abs R. Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome. Clin. Endocrinol. 2000;53:99–106. doi: 10.1046/j.1365-2265.2000.01049.x.
    1. Ottenweller J.E., Sisto S.A., McCarty R.C., Natelson B.H. Hormonal responses to exercise in chronic fatigue syndrome. Neuropsychobiology. 2001;43:34–41. doi: 10.1159/000054863.
    1. Gupta S., Vayuvegula B. A comprehensive immunological analysis in chronic fatigue syndrome. Scand. J. Immunol. 1991;33:319–327. doi: 10.1111/j.1365-3083.1991.tb01777.x.
    1. Natelson B.H., LaManca J.J., Denny T.N., Vladutiu A., Oleske J., Hill N., Bergen M.T., Korn L., Hay J. Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis. Am. J. Med. 1998;105:43s–49s. doi: 10.1016/S0002-9343(98)00165-X.
    1. Milton J.D., Clements G.B., Edwards R.H. Immune responsiveness in chronic fatigue syndrome. Postgrad Med. J. 1991;67:532–537. doi: 10.1136/pgmj.67.788.532.
    1. Bennett A.L., Fagioli L.R., Schur P.H., Schacterle R.S., Komaroff A.L. Immunoglobulin subclass levels in chronic fatigue syndrome. J. Clin. Immunol. 1996;16:315–320. doi: 10.1007/BF01541666.
    1. Skowera A., Stewart E., Davis E.T., Cleare A.J., Unwin C., Hull L., Ismail K., Hossain G., Wessely S.C., Peakman M. Antinuclear autoantibodies (±ANA) in Gulf War-related illness and chronic fatigue syndrome (±CFS) patients. Clin. Exp. Immunol. 2002;129:354–358. doi: 10.1046/j.1365-2249.2002.01912.x.
    1. Rahman K., Burton A., Galbraith S., Lloyd A., Vollmer-Conna U. Sleep-wake behavior in chronic fatigue syndrome. Sleep. 2011;34:671–678. doi: 10.1093/sleep/34.5.671.
    1. Wood B., Wessely S., Papadopoulos A., Poon L., Checkley S. Salivary cortisol profiles in chronic fatigue syndrome. Neuropsychobiology. 1998;37:1–4. doi: 10.1159/000026469.
    1. Lloyd A.R., Wakefield D., Boughton C.R., Dwyer J.M. Immunological abnormalities in the chronic fatigue syndrome. Med. J. Aust. 1989;151:122–124. doi: 10.5694/j.1326-5377.1989.tb139594.x.
    1. De Lorenzo F. Chronic fatigue syndrome: Physical and cardiovascular deconditioning. QJM. 1998;91:475–481. doi: 10.1093/qjmed/91.7.475.
    1. Bates D.W., Buchwald D., Lee J., Kith P., Doolittle T., Rutherford C., Cherchill W.H., Scher P.H., Wenert M., Wybenga D. Clinical laboratory test findings in patients with chronic fatigue syndrome. Arch. Intern. Med. 1995;155:97–103. doi: 10.1001/archinte.1995.00430010105014.
    1. Groven N., Fors E.A., Reitan S.K. Patients with Fibromyalgia and Chronic Fatigue Syndrome show increased hsCRP compared to healthy controls. Brain Behav. Immun. 2019;81:172–177. doi: 10.1016/j.bbi.2019.06.010.
    1. Strawbridge R., Sartor M.L., Scott F., Cleare A.J. Inflammatory proteins are altered in chronic fatigue syndrome-A systematic review and meta-analysis. Neurosci. Biobehav. Rev. 2019;107:69–83. doi: 10.1016/j.neubiorev.2019.08.011.
    1. Sorensen B., Streib J.E., Strand M., Make B., Giclas P.C., Fleshner M., Jones J.F. Complement activation in a model of chronic fatigue syndrome. J. Allergy Clin. Immunol. 2003;112:397–403. doi: 10.1067/mai.2003.1615.
    1. Germain A., Ruppert D., Levine S.M., Hanson M.R. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism. Mol. Biosyst. 2017;13:371–379. doi: 10.1039/C6MB00600K.
    1. Jacobson W., Saich T., Borysiewicz L.K., Behan W.M., Behan P.O., Wreghitt T.G. Serum folate and chronic fatigue syndrome. Neurology. 1993;43:2645–2647. doi: 10.1212/WNL.43.12.2645.
    1. Roerink M.E., Roerink S., Skoluda N., Van der Schaaf M.E., Hermus A., Van der Meer J.W.M., Knoop H., Nater U.M. Hair and salivary cortisol in a cohort of women with chronic fatigue syndrome. Horm. Behav. 2018;103:1–6. doi: 10.1016/j.yhbeh.2018.05.016.
    1. Nijhof S.L., Rutten J.M.T.M., Uiterwaal C.S.P.M., Bleijenberg G., Kimpen J.L.L., Putte E.M.V.D. The role of hypocortisolism in chronic fatigue syndrome. Psychoneuroendocrinology. 2014;42:199–206. doi: 10.1016/j.psyneuen.2014.01.017.
    1. Strickland P., Morriss R., Wearden A., Deakin B. A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls. J. Affect. Disord. 1998;47:191–194. doi: 10.1016/S0165-0327(97)00134-1.
    1. Rimes K.A., Papadopoulos A.S., Cleare A.J., Chalder T. Cortisol output in adolescents with chronic fatigue syndrome: Pilot study on the comparison with healthy adolescents and change after cognitive behavioural guided self-help treatment. J. Psychosom. Res. 2014;77:409–414. doi: 10.1016/j.jpsychores.2014.08.018.
    1. Jerjes W.K., Peters T.J., Taylor N.F., Wood P.J., Wessely S., Cleare A.J. Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome. J. Psychosom. Res. 2006;60:145–153. doi: 10.1016/j.jpsychores.2005.07.008.
    1. Roberts A.D., Wessely S., Chalder T., Papadopoulos A., Cleare A.J. Salivary cortisol response to awakening in chronic fatigue syndrome. Br. J. Psychiatry. 2004;184:136–141. doi: 10.1192/bjp.184.2.136.
    1. Wyller V.B., Vitelli V., Sulheim D., Fagermoen E., Winger A., Godang K., Bollerslev J. Altered neuroendocrine control and association to clinical symptoms in adolescent chronic fatigue syndrome: A cross-sectional study. J. Transl. Med. 2016;14:1–12. doi: 10.1186/s12967-016-0873-1.
    1. Wakefield D., Lloyd A., Brockman A. Immunoglobulin subclass abnormalities in patients with chronic fatigue syndrome. Pediatr. Infect. Dis. J. 1990;9:550–553. doi: 10.1097/00006454-199008001-00009.
    1. Guenther S., Loebel M., Mooslechner A.A., Knops M., Hanitsch L.G., Grabowski P., Wittke K., Meisel C., Unterwalder N., Volk H.-D., et al. Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome. Hum. Immunol. 2015;76:729–735. doi: 10.1016/j.humimm.2015.09.028.
    1. Natelson B.H., Lin J.S., Lange G., Khan S., Stegner A., Unger E.R. The effect of comorbid medical and psychiatric diagnoses on chronic fatigue syndrome. Ann. Med. 2019;51:371–378. doi: 10.1080/07853890.2019.1683601.
    1. Brurberg K.G., Fønhus M.S., Larun L., Flottorp S., Malterud K. Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (±CFS/ME): A systematic review. BMJ Open. 2014;4:e003973. doi: 10.1136/bmjopen-2013-003973.
    1. Brown A., Molly B., Porter N., Meredyth E., Jason L., Jessica H., Anderson V., Lerch A., De Meirleir K., Friedberg F. The development of a revised canadian myalgic encephalomyelitis chronic fatigue syndrome case definition. Am. J. Biochem. Biotechnol. 2010;6:120–135.
    1. Hawk C., Jason L.A., Torres-Harding S. Differential diagnosis of chronic fatigue syndrome and major depressive disorder. Int. J. Behav. Med. 2006;13:244–251. doi: 10.1207/s15327558ijbm1303_8.
    1. Brown A.A., Jason L.A. Validating a measure of myalgic encephalomyelitis/chronic fatigue syndrome symptomatology. Fatigue. 2014;2:132–152. doi: 10.1080/21641846.2014.928014.
    1. Jason L.A., So S., Brown A.A., Sunnquist M., Evans M. Test-Retest Reliability of the DePaul Symptom Questionnaire. Fatigue. 2015;3:16–32. doi: 10.1080/21641846.2014.978110.
    1. Strand E., Lillestøl K., Jason L., Tveito K., Diep L., Valla S., Sunnquist M., Helland I.B., Herder I., Dammen T. Comparing the DePaul Symptom Questionnaire with physician assessments: A preliminary study. Routledge Fr. Taylor Group. 2016;4:52–62. doi: 10.1080/21641846.2015.1126026.
    1. Murdock K.W., Wang X.S., Shi Q., Cleeland C.S., Fagundes C.P., Vernon S.D. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome. Qual. Life Res. 2017;26:913–921. doi: 10.1007/s11136-016-1406-3.
    1. Teixeira A., Borges G. Creatine Kinase: Structure and function. Braz. J. Biomotricity. 2012;6:53–65.
    1. Baird M.F., Graham S.M., Baker J.S., Bickerstaff G.F. Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery. J. Nutr. Metab. 2012;2012:960363. doi: 10.1155/2012/960363.
    1. Stucki G., Brühlmann P., Stoll T., Stucki S., Willer B., Michel B.A. Low serum creatine kinase activity is associated with muscle weakness in patients with rheumatoid arthritis. J. Rheumatol. 1996;23:603–608.
    1. Van Campen C.L.M., Riepma K., Visser F.C. Open trial of vitamin b12 nasal drops in adults with myalgic encephalomyelitis/chronic fatigue syndrome: Comparison of responders and non-responders. Front. Pharmacol. 2019;10:1102. doi: 10.3389/fphar.2019.01102.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다